It has been previously shown that rotavirus triplelayered particles induce permeabilization of liposomes and membrane vesicles. These effects were mediated by one or both of the solubilized outer-capsid proteins, VP4 and VP7. Permeabilization was dependent on trypsin treatment of the viral particles, suggesting that VP4 was involved. To analyse the respective roles of the outer-capsid proteins in this permeabilization process, we have used membrane vesicles loaded with carboxyfluorescein and virus-like particles derived from insect cells co-expressing various sets of capsid proteins. Virus-like particles containing VP2, VP6 and VP7 (VLP2/6/7) are as efficient in permeabilizing vesicles as triple-layered particles. As with double-layered particles, virus-like particles made of VP2 and VP6 had no effect on vesicle permeabilization. Permeabilization of membrane vesicles required trypsinization of the VP7 solubilized from VLP2/6/7. These results show that solubilized and trypsinized VP7 is able to induce membrane permeabilization, independently of the presence of VP4.
It has been previously shown that rotavirus triplelayered particles induce permeabilization of liposomes and membrane vesicles. These effects were mediated by one or both of the solubilized outer-capsid proteins, VP4 and VP7. Permeabilization was dependent on trypsin treatment of the viral particles, suggesting that VP4 was involved. To analyse the respective roles of the outer-capsid proteins in this permeabilization process, we have used membrane vesicles loaded with carboxyfluorescein and virus-like particles derived from insect cells co-expressing various sets of capsid proteins. Virus-like particles containing VP2, VP6 and VP7 (VLP2/6/7) are as efficient in permeabilizing vesicles as triple-layered particles. As with double-layered particles, virus-like particles made of VP2 and VP6 had no effect on vesicle permeabilization. Permeabilization of membrane vesicles required trypsinization of the VP7 solubilized from VLP2/6/7. These results show that solubilized and trypsinized VP7 is able to induce membrane permeabilization, independently of the presence of VP4.
Rotavirus, a member of the family Reoviridae, is a nonenveloped virus which has a triple-layered concentric protein structure containing the genome (11 segments of doublestranded RNA) and two minor proteins, VP1 and VP3 (Yeager et al., 1990 ; Prasad et al., 1988 ; Mattion et al., 1994) . The innermost protein layer is composed of VP2 and the second of VP6. The third, outer layer consists of the glycoprotein VP7 and the protein VP4. Treatment of rotaviral particles by trypsin cleaves VP4 into VP5* and VP8*, and enhances Author for correspondence : M. C. Ruiz.
Fax j58 2 504 1093. e-mail mclr!cbb.ivic.ve rotavirus infectivity (Clark et al., 1981) . Infection of the cell by rotaviruses is thought to be a multi-step process involving attachment to specific membrane receptor(s), entry into the cell and uncoating to trigger virus replication. Rotavirus attachment to the cells seems to involve the binding of VP4 to a membrane receptor (Ludert et al., 1996 ; Mendez et al., 1996) , but the mechanism of rotavirus penetration into the cell remains unknown. Two pathways of entry have been proposed, the direct and the endocytosis pathways (Suzuki et al., 1985) . Both of these pathways require the crossing of a cellular membrane, either the plasma membrane in the case of direct entry, or the endosomal membrane following endocytosis.
It has been shown previously that rotavirus has the capacity to induce fusion of plasma membranes and syncytium formation in cultured cells (Falconer et al., 1995) . On the other hand, rotavirus can permeabilize liposomes, membrane vesicles and intact cells (Nandi et al., 1992 ; Ruiz et al., 1994 Ruiz et al., , 1995 , but only trypsinized triple-layered particles (TLP) induce this effect. Permeabilization involves interactions between solubilized outer-layer proteins of rotavirus and membrane lipids. It is not known whether one or both of the outer-layer proteins, VP4 and VP7, are necessary to induce membrane permeabilization. The requirement for trypsinization of viral particles suggests the participation of either VP4 or one of its cleavage products, VP5* and VP8*. However, at present there is no direct evidence concerning this point.
In the present study, we have analysed the role of the outer-capsid protein VP7 in membrane permeabilization by using membrane vesicles loaded with a fluorophore, and viruslike particles (VLP) derived from insect cells co-expressing capsid proteins VP2, VP6 and VP7 (VLP2\6\7), but not VP4.
VLP were produced by co-infecting Sf9 cells with recombinant baculoviruses at an m.o.i. of 5 p.f.u. per cell. The recombinant baculoviruses BacRF2, BacRF6 and BacRF9 containing genes 2, 6 and 9 of the bovine RF strain, respectively, were prepared as previously described (Labbe! et al., 1991 ; Tosser et al., 1992 ; Ruiz et al., 1996) . VLP were purified by banding twice in CsCl gradients in 20 mM PIPES pH 6n6 0001-4255 # 1997 SGM BDGH A. Charpilienne and others A. Charpilienne and others Fig. 1 . CF release induced by purified VLP2/6/7. (A) Either VLP2/6/7, VLP2/6 or trypsinized triple-layered particles (TLP) were added at time zero to a cuvette containing CF-loaded vesicles suspended in 300 µl of SAM supplemented with 1 mM EGTA. Trypsin (5 µg/ml, final concentration) was added to the cuvette containing either VLP2/6/7 or VLP2/6 as indicated by the arrow. (B) At time zero, pre-trypsinized VLP2/6/7 or VLP2/6 (trypsin concentration of 5 µg/ml, 5 min at 37 mC ; upon dilution in the cuvette, final concentration of trypsin was 0n16 µg/ml) were added to 300 µl of SAM containing CF-loaded vesicles and 1 mM CaCl 2 . At the arrow, EGTA (10 mM final concentration) was added to both VLP assays. Final protein concentrations were 20 µg/ml for membranes, and 40 µg/ml for each VLP2/6, VLP2/6/7 and TLP. (C) Effect of 10 mM EGTA on the apparent size of the VLP as measured by light scattering. At time zero, 8 µl of either VLP2/6/7 or VLP2/6 (1n5 mg/ml) were added to the cuvette containing 1 ml of SAM supplemented with 1 mM CaCl 2 . EGTA (10 mM final concentration) was added to the cuvette as indicated by the arrow. (D) In both curves (a) and (b), VLP2/6/7 (20 µl at 0n8 mg/ml), were pretreated outside the cuvette (for 2 min at 37 mC, in a final volume of 24 µl) with either 10 mM EGTA (curve a) or with 5 µg/ml trypsin plus 1 mM CaCl 2 (curve b). Either mixture (denoted by the box enclosures) was added to a cuvette containing CFloaded vesicles suspended in 300 µl of SAM supplemented with either 5 µg/ml trypsin plus 2 mM CaCl 2 (curve a) or 1 mM CaCl 2 (curve b). In curve b, further additions of EGTA and trypsin (10 mM and 5 µg/ml final concentration, respectively) were made directly into the cuvette at the indicated times.
containing 10 mM CaCl # (18 h at 35 000 r.p.m. in an SW50.2 rotor). The TLP used as controls were grown in MA104 cells in the presence of trypsin (0n44 mg\ml, Sigma type IX) and purified after Freon 113 extraction by banding twice in CsCl gradients.
Membrane permeabilization assays were performed by using brush border membrane vesicles loaded with the selfquenching fluorophore 6-carboxyfluorescein (CF) as previously described (Ruiz et al., 1994) . Vesicles were prepared from pig jejunum by using the magnesium-EGTA precipitation method of Hauser et al. (1980) . Vesicles loaded with the fluorophore were resuspended in a standard assay medium (SAM) consisting of 100 mM sorbitol and 200 mM Tris-HCl in a pH 7n4 buffer (20 mM HEPES\10 mM Tris). CF release was monitored at 37 mC as a fluorescence increase due to dilution dequenching in a spectrofluorometer (Photon Technology International) equipped with stirrer and temperature control. Excitation and emission wavelengths were 496 and 520 nm, respectively. The results are expressed as percentages of the total fluorescence, determined after the addition of digitonin (0n13 mg\ml final concentration) at the end of each experiment.
Changes in the diameters of VLP2\6\7 and VLP2\6 were monitored by 90m light scattering. An 8 µl volume of purified VLP at a concentration of 1n5 mg\ml was added to the cuvette of the fluorometer (37 mC) which contained 1 ml of SAM supplemented with 1 mM CaCl # . Slits were adjusted to 0n5-1 nm and both monochromators were set at a wavelength of 300 nm.
Protein modifications resulting from trypsin treatment of the different types of particles were analysed by SDS-PAGE BDGI Membrane permeabilization by rotavirus VP7 Membrane permeabilization by rotavirus VP7 Fig. 2. (A) Effect of trypsin concentration on CF release from vesicles induced by VLP2/6/7 suspended in SAM (300 µl) containing 1 mM EGTA. Trypsin was added at the arrow. Numbers on the right denote final trypsin concentrations. The control curve corresponds to the addition of 15 µg/ml trypsin to the vesicle suspension in the absence of VLP2/6/7. Protein concentrations were 18 µg/ml for membranes and 40 µg/ml for VLP2/6/7. (B) Comparison between the trypsin and chymotrypsin effects on VLP2/6/7-induced CF release. VLP2/6/7 (40 µg/ml final concentration) were added to CF-loaded vesicles suspended in 300 µl of SAM plus 1 mM EGTA. Final enzyme concentrations were 5 µg/ml in both cases. (C) Effect of the trypsin inhibitor TLCK on VLP2/6/7-induced CF release. VLP2/6/7 (20 µl at 0n8 mg/ml) were treated (outside the cuvette, for 1 min at 37 mC) with EGTA and trypsin (10 mM and 5 µg/ml final concentrations, respectively) in the presence or absence of TLCK (15 µg/ml). Either mixture (denoted by the box enclosure) was added to a cuvette containing CF-loaded vesicles suspended in 300 µl of SAM supplemented with 1 mM CaCl 2 .
on 12 % polyacrylamide gels. Gels were stained with Coomassie blue.
Addition of VLP2\6\7 to vesicles resuspended in SAM containing 1 mM EGTA had no effect, but CF release was observed as soon as trypsin was added to the cuvette (Fig. 1 A) . This effect was not obtained with trypsinized or untreated VLP2\6, or when trypsin alone was added. The addition of VLP2\6\7 into SAM supplemented with 1 mM CaCl # and trypsin did not induce vesicle permeabilization (Fig. 1B) . However, CF release took place immediately after Ca# + chelation by EGTA. Comparison of the kinetics of CF release induced by VLP2\6\7 (Fig. 1 B) and by TLP (Fig. 1 A) , revealed a similar pattern.
Since it has been shown that low Ca# + concentration induces VP7 solubilization from VLP2\6\7 (Ruiz et al., 1996) , we studied the kinetics of this process and compared it with the time-course of the permeabilizing effect. We observed that the addition of 10 mM EGTA to VLP2\6\7 induced an immediate decrease in the scattering signal corresponding to a reduction in the diameter of the particles (Fig. 1 C) . The time necessary for total VP7 solubilization (at 37 mC and zero Ca# + ) was much shorter than that preceding the onset of permeabilization. No change in scattering signal was observed when VLP2\6 were treated with EGTA. Addition of trypsin before or after EGTA did not modify the apparent diameter of the particles (not shown). These results show that the permeabilizing effect of VLP2\6\7 required not only treatment of VP7 with trypsin, but also solubilization of this viral protein. Results are similar to those previously described for TLP, where both solubilization and trypsinization of the outer-capsid proteins were required for permeabilization (Ruiz et al., 1994) . For TLP, it has been shown that permeabilization was due to the solubilized outer-capsid proteins (Ruiz et al., 1994) .
To see whether trypsin cleavage of VP7 could take place in either the solubilized or the native state, controlled trypsinization was performed both before and after VP7 solubilization by EGTA treatment (Fig. 1 D) . Addition of a suspension of VLP2\6\7, in which VP7 was first solubilized by EGTA pre-treatment outside the cuvette, to vesicles incubated in SAM containing 2 mM CaCl # and trypsin, induced CF release (Fig. 1 D, curve a) . This result indicates that solubilized VP7 can be modified by the action of trypsin and thereby induce permeabilization even in the presence of 1n3 mM free Ca# + . This shows that Ca# + does not inhibit either vesicle permeabilization or the action of trypsin on VP7 when this protein is first solubilized. When intact VLP2\6\7 (in the presence of 1 mM Ca# + ) were treated with trypsin and added to the vesicle suspension in the presence of 1 mM Ca# + , no CF release was observed (Fig. 1 D, curve b) . Further addition of EGTA to solubilize VP7 had only a small effect, most probably due to the low concentration of trypsin in the cuvette derived from the VLP sample. Full restoration of permeabilization was attained when more trypsin was added to the cuvette. This result indicates that trypsin had no effect whatsoever when VP7 was attached to the intact VLP2\6\7 particle, but was effective on the solubilized protein.
The rate of vesicle permeabilization was a function of trypsin concentration (Fig. 2 A) . The trypsin concentrations used were in the same range as those needed either to enhance rotavirus infectivity (Clark et al., 1981) or to activate untrypsinized TLP in the CF release assay (Ruiz et al., 1994) . The effect of trypsin does not seem to take place directly over A. Charpilienne and others A. Charpilienne and others Fig. 3 . Effect of trypsin treatment on the electrophoretic mobility of VLP and TLP proteins. Purified DLP (double-layered particles), TLP, VLP2/6/7 and VLP2/6 were analysed by SDS-PAGE after sequential treatment (10 min at 37 mC) with or without 10 mM EGTA and with or without 5 µg/ml trypsin. Viral proteins are identified on the left side and molecular mass markers (kDa) on the right side.
the membrane. Vesicles treated with trypsin, and then washed, did not permeabilize by themselves or upon the addition of VLP2\6\7 in the presence of EGTA (not shown). The action of trypsin was specific since chymotrypsin did not have the same effect (Fig. 2 B) and was inhibited by TLCK (Nα-p-tosyl--lysine chloromethyl ketone), a specific inhibitor of trypsin (Fig. 2 C) .
To detect the protein modifications induced by trypsin, we analysed the mobility of viral proteins from TLP and VLP2\6\7 by SDS-PAGE after various treatments (Fig. 3) . The gels indicate that trypsin digestion of VPL2\6\7 or TLP treated with EGTA to solubilize the outer-capsid proteins resulted in the disappearance of the VP7 band and the appearance of new bands of lower molecular mass. On the other hand, the mobility of VP7 was not affected when the protein was bound to the particles (VPL2\6\7 or TLP) during trypsin treatment. Solubilization of the outer-capsid proteins by EGTA did not affect the migration of the TLP and VLP2\6\7 proteins (data not shown).
It is well known that trypsin induces the cleavage of VP4 but, to our knowledge, there is no report of any effect of trypsin on VP7. Our experiments indicate that the sites of trypsin cleavage on VP7 are inaccessible in the intact particle. Solubilization appears to expose trypsin sites. One or several of the resulting peptides would be able to destabilize the vesicle membrane and induce the leakage of CF.
In light of these and other results, we suggest that VP4 also has permeabilizing capacity. Trypsinized TLP, in which we now know that VP4 is cleaved but not VP7, are able to elicit permeabilization upon solubilization of the outer capsid by EGTA (Ruiz et al., 1994 ; Nandi et al., 1992) . Furthermore, the trypsinized supernatant of a lysate of Sf9 cells expressing VP4 induced permeabilization (Alaoui et al., 1997) . Therefore, it appears that both cleaved VP4 and VP7 are each able to induce permeabilization independently. It seems clear that both VP7 and VP4 need to be solubilized and trypsinized to induce destabilization of the membrane, although the exact role of each one of the proteins in this process and, moreover, in the replication of rotavirus, is not known. Interestingly, this permeabilizing property is also shared by the nonstructural rotavirus protein NSP4 (Tian et al., 1996) . Interaction of hydrophobic regions of viral proteins with membrane lipids may play an important role in the different stages of the virus replication cycle. The specific interactions of VP4 and VP7 with the cellular membrane remain to be elucidated in order to understand the penetration mechanism of infectious rotavirus particles into the cell.
